Black Diamond Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +546.1% | +205.4% | +108.3% | -24.9% | -36.9% | +1.5% | -22.7% | +16.6% | |
| – | +553.1% | +201.3% | +105.2% | -32.5% | -40.8% | +5.0% | -24.5% | +30.9% | |
| – | +555.8% | +199.4% | -77.6% | +90.1% | -47.8% | +63.8% | -35.2% | -42.4% | |
| – | +555.8% | +199.4% | +103.7% | -33.4% | -41.5% | +7.0% | -25.0% | +30.5% | |
| – | +31.4% | +22.4% | +5,257.9% | +249.8% | -91.6% | – | – | – | |
| – | +358.4% | +205.0% | -89.3% | +136.3% | -21.7% | +3.1% | -5.9% | -21.7% | |
| – | +15.5% | +88.9% | +192.4% | +66.3% | -35.4% | +28.7% | +4.7% | -23.5% | |
| – | – | – | – | -69.4% | +787.8% | +9.6% | +9.3% | +9.1% | |
| – | +173.7% | +372.1% | +29.2% | +61.8% | -54.3% | +23.8% | +72.4% | -85.6% | |
| – | – | – | – | -36.3% | -40.9% | +0.9% | -28.7% | +34.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | +93.9% | +157.4% | -8.4% | +10.0% | +0.1% | +21.3% | +25.2% | +4.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.